成長ホルモン阻害ホルモンの世界市場2020-2026:オクトレオチド、ランレオチド、パシレオチド、その他

QYResearchが発行した調査報告書(QYR20AP00914)
◆英語タイトル:Global Growth Hormone-inhibiting Hormone Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP00914
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:114
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、成長ホルモン阻害ホルモンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、成長ホルモン阻害ホルモンのグローバル市場動向、メーカー別競争状況、種類別市場規模(オクトレオチド、ランレオチド、パシレオチド、その他)、用途別市場規模(病院、薬局、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・成長ホルモン阻害ホルモンの種類別市場2015-2026:オクトレオチド、ランレオチド、パシレオチド、その他
・成長ホルモン阻害ホルモンの用途別市場2015-2026:病院、薬局、その他
・成長ホルモン阻害ホルモンの北米市場分析
・成長ホルモン阻害ホルモンのアジア市場分析
・成長ホルモン阻害ホルモンの中南米市場分析
・成長ホルモン阻害ホルモンの中東・アフリカ市場分析
・関連企業情報:Novartis、Pfizer、Ispen、HYBIO、TianTaiShan
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.In 2019, the global Growth Hormone-inhibiting Hormone market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Growth Hormone-inhibiting Hormone.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Growth Hormone-inhibiting Hormone market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Growth Hormone-inhibiting Hormone market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Growth Hormone-inhibiting Hormone market. Readers of the report can become informed about current and future trends of the global Growth Hormone-inhibiting Hormone market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Growth Hormone-inhibiting Hormone markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Growth Hormone-inhibiting Hormone market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Growth Hormone-inhibiting Hormone market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Growth Hormone-inhibiting Hormone market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Growth Hormone-inhibiting Hormone market is segmented into
Octreotide
Lanreotide
Pasireotide
Other

Market Segment by Application, the Growth Hormone-inhibiting Hormone market is segmented into
Hospital
Pharmacy
Other

This report includes the following manufacturers; we can also add the other companies as you want.
Novartis
Pfizer
Ispen
HYBIO
TianTaiShan

The study objectives are:
To analyze and research the global Growth Hormone-inhibiting Hormone status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Growth Hormone-inhibiting Hormone manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Growth Hormone-inhibiting Hormone are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Growth Hormone-inhibiting Hormone Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Growth Hormone-inhibiting Hormone Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Octreotide
1.3.3 Lanreotide
1.3.4 Pasireotide
1.3.5 Other
1.4 Market Segment by Application
1.4.1 Global Growth Hormone-inhibiting Hormone Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospital
1.4.3 Pharmacy
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Growth Hormone-inhibiting Hormone Revenue (2015-2026)
2.1.1 Global Growth Hormone-inhibiting Hormone Revenue (2015-2026)
2.1.2 Global Growth Hormone-inhibiting Hormone Sales (2015-2026)
2.2 Growth Hormone-inhibiting Hormone Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Growth Hormone-inhibiting Hormone Sales by Regions (2015-2020)
2.2.2 Global Growth Hormone-inhibiting Hormone Revenue by Regions (2015-2020)
2.3 Global Top Growth Hormone-inhibiting Hormone Regions (Countries) Ranking by Market Size
2.4 Growth Hormone-inhibiting Hormone Industry Trends
2.4.1 Growth Hormone-inhibiting Hormone Market Top Trends
2.4.2 Market Drivers
2.4.3 Growth Hormone-inhibiting Hormone Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Growth Hormone-inhibiting Hormone Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Growth Hormone-inhibiting Hormone Manufacturers by Sales (2015-2020)
3.1.1 Global Growth Hormone-inhibiting Hormone Sales by Manufacturers (2015-2020)
3.1.2 Global Growth Hormone-inhibiting Hormone Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Growth Hormone-inhibiting Hormone Sales in 2019
3.2 Global Top Manufacturers Growth Hormone-inhibiting Hormone by Revenue
3.2.1 Global Growth Hormone-inhibiting Hormone Revenue by Manufacturers (2015-2020)
3.2.2 Global Growth Hormone-inhibiting Hormone Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Growth Hormone-inhibiting Hormone Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Growth Hormone-inhibiting Hormone as of 2019)
3.4 Global Growth Hormone-inhibiting Hormone Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Growth Hormone-inhibiting Hormone Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Growth Hormone-inhibiting Hormone Market
3.7 Key Manufacturers Growth Hormone-inhibiting Hormone Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Growth Hormone-inhibiting Hormone Historic Market Review by Type (2015-2020)
4.1.2 Global Growth Hormone-inhibiting Hormone Sales Market Share by Type (2015-2020)
4.1.3 Global Growth Hormone-inhibiting Hormone Revenue Market Share by Type (2015-2020)
4.1.4 Growth Hormone-inhibiting Hormone Price by Type (2015-2020)
4.1 Global Growth Hormone-inhibiting Hormone Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Growth Hormone-inhibiting Hormone Sales Forecast by Type (2021-2026)
4.2.3 Global Growth Hormone-inhibiting Hormone Revenue Forecast by Type (2021-2026)
4.2.4 Growth Hormone-inhibiting Hormone Price Forecast by Type (2021-2026)

5 Global Growth Hormone-inhibiting Hormone Market Size by Application
5.1 Global Growth Hormone-inhibiting Hormone Historic Market Review by Application (2015-2020)
5.1.2 Global Growth Hormone-inhibiting Hormone Sales Market Share by Application (2015-2020)
5.1.3 Global Growth Hormone-inhibiting Hormone Revenue Market Share by Application (2015-2020)
5.1.4 Growth Hormone-inhibiting Hormone Price by Application (2015-2020)
5.2 Global Growth Hormone-inhibiting Hormone Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Growth Hormone-inhibiting Hormone Sales Forecast by Application (2021-2026)
5.2.3 Global Growth Hormone-inhibiting Hormone Revenue Forecast by Application (2021-2026)
5.2.4 Growth Hormone-inhibiting Hormone Price Forecast by Application (2021-2026)

6 North America
6.1 North America Growth Hormone-inhibiting Hormone Breakdown Data by Company
6.2 North America Growth Hormone-inhibiting Hormone Breakdown Data by Type
6.3 North America Growth Hormone-inhibiting Hormone Breakdown Data by Application
6.4 North America Growth Hormone-inhibiting Hormone Breakdown Data by Countries
6.4.1 North America Growth Hormone-inhibiting Hormone Sales by Countries
6.4.2 North America Growth Hormone-inhibiting Hormone Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Growth Hormone-inhibiting Hormone Breakdown Data by Company
7.2 Europe Growth Hormone-inhibiting Hormone Breakdown Data by Type
7.3 Europe Growth Hormone-inhibiting Hormone Breakdown Data by Application
7.4 Europe Growth Hormone-inhibiting Hormone Breakdown Data by Countries
7.4.1 Europe Growth Hormone-inhibiting Hormone Sales by Countries
7.4.2 Europe Growth Hormone-inhibiting Hormone Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Growth Hormone-inhibiting Hormone Breakdown Data by Company
8.2 Asia Pacific Growth Hormone-inhibiting Hormone Breakdown Data by Type
8.3 Asia Pacific Growth Hormone-inhibiting Hormone Breakdown Data by Application
8.4 Asia Pacific Growth Hormone-inhibiting Hormone Breakdown Data by Regions
8.4.1 Asia Pacific Growth Hormone-inhibiting Hormone Sales by Regions
8.4.2 Asia Pacific Growth Hormone-inhibiting Hormone Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Growth Hormone-inhibiting Hormone Breakdown Data by Company
9.2 Latin America Growth Hormone-inhibiting Hormone Breakdown Data by Type
9.3 Latin America Growth Hormone-inhibiting Hormone Breakdown Data by Application
9.4 Latin America Growth Hormone-inhibiting Hormone Breakdown Data by Countries
9.4.1 Latin America Growth Hormone-inhibiting Hormone Sales by Countries
9.4.2 Latin America Growth Hormone-inhibiting Hormone Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Growth Hormone-inhibiting Hormone Breakdown Data by Type
10.2 Middle East and Africa Growth Hormone-inhibiting Hormone Breakdown Data by Application
10.3 Middle East and Africa Growth Hormone-inhibiting Hormone Breakdown Data by Countries
10.3.1 Middle East and Africa Growth Hormone-inhibiting Hormone Sales by Countries
10.3.2 Middle East and Africa Growth Hormone-inhibiting Hormone Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Novartis Growth Hormone-inhibiting Hormone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Novartis Growth Hormone-inhibiting Hormone Products and Services
11.1.5 Novartis SWOT Analysis
11.1.6 Novartis Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Pfizer Growth Hormone-inhibiting Hormone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Pfizer Growth Hormone-inhibiting Hormone Products and Services
11.2.5 Pfizer SWOT Analysis
11.2.6 Pfizer Recent Developments
11.3 Ispen
11.3.1 Ispen Corporation Information
11.3.2 Ispen Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Ispen Growth Hormone-inhibiting Hormone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Ispen Growth Hormone-inhibiting Hormone Products and Services
11.3.5 Ispen SWOT Analysis
11.3.6 Ispen Recent Developments
11.4 HYBIO
11.4.1 HYBIO Corporation Information
11.4.2 HYBIO Business Overview and Total Revenue (2019 VS 2018)
11.4.3 HYBIO Growth Hormone-inhibiting Hormone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 HYBIO Growth Hormone-inhibiting Hormone Products and Services
11.4.5 HYBIO SWOT Analysis
11.4.6 HYBIO Recent Developments
11.5 TianTaiShan
11.5.1 TianTaiShan Corporation Information
11.5.2 TianTaiShan Business Overview and Total Revenue (2019 VS 2018)
11.5.3 TianTaiShan Growth Hormone-inhibiting Hormone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 TianTaiShan Growth Hormone-inhibiting Hormone Products and Services
11.5.5 TianTaiShan SWOT Analysis
11.5.6 TianTaiShan Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Growth Hormone-inhibiting Hormone Sales Channels
12.2.2 Growth Hormone-inhibiting Hormone Distributors
12.3 Growth Hormone-inhibiting Hormone Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Growth Hormone-inhibiting Hormone Sales Forecast (2021-2026)
13.1.1 Global Growth Hormone-inhibiting Hormone Sales Forecast by Regions (2021-2026)
13.1.2 Global Growth Hormone-inhibiting Hormone Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Growth Hormone-inhibiting Hormone Sales Forecast (2021-2026)
13.2.2 North America Growth Hormone-inhibiting Hormone Revenue Forecast (2021-2026)
13.2.3 North America Growth Hormone-inhibiting Hormone Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Growth Hormone-inhibiting Hormone Sales Forecast (2021-2026)
13.3.2 Europe Growth Hormone-inhibiting Hormone Revenue Forecast (2021-2026)
13.3.3 Europe Growth Hormone-inhibiting Hormone Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Growth Hormone-inhibiting Hormone Sales Forecast (2021-2026)
13.4.2 Asia Pacific Growth Hormone-inhibiting Hormone Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Growth Hormone-inhibiting Hormone Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Growth Hormone-inhibiting Hormone Sales Forecast (2021-2026)
13.5.2 Latin America Growth Hormone-inhibiting Hormone Revenue Forecast (2021-2026)
13.5.3 Latin America Growth Hormone-inhibiting Hormone Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Growth Hormone-inhibiting Hormone Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Growth Hormone-inhibiting Hormone Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Growth Hormone-inhibiting Hormone Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Novartis、Pfizer、Ispen、HYBIO、TianTaiShan

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 成長ホルモン阻害ホルモンの世界市場2020-2026:オクトレオチド、ランレオチド、パシレオチド、その他(Global Growth Hormone-inhibiting Hormone Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。